Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Growblox Sciences Inc (GBLX)

Growblox Sciences Inc (GBLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
GB Sciences Announces Outstanding Results from Preclinical Study of Its Parkinson's Disease Formulations

In an animal model of the disease, GB Sciences' formulations were able to reduce Parkinson's disease-like behavioral symptoms 'back to baseline' with negligible side effects.

GBLX : 0.0390 (+0.52%)
GB Sciences Announces Outstanding Results from Preclinical Study of Its Parkinson's Disease Formulations

In an animal model of the disease, GB Sciences' formulations were able to reduce Parkinson's disease-like behavioral symptoms 'back to baseline' with negligible side effects.

GBLX : 0.0390 (+0.52%)
GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson's Disease and Neuropathic Pain

GB Sciences, Inc. (OTCQB: GBLX) announced the execution of a Binding Letter of Intent for the Sale of 75% of its membership interests in the Company's Las Vegas, Nevada cultivation and production operation....

GBLX : 0.0390 (+0.52%)
GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson's Disease and Neuropathic Pain

LAS VEGAS , Dec. 5, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announced the execution of a Binding Letter of Intent for the Sale of 75% of its membership interests in the Company's ...

GBLX : 0.0390 (+0.52%)
Shifting Regulations Open New Doors for the CBD Industry

The U.S. cannabidiol market burgeoned after the passage of the Farm Bill in 2018. The Farm Bill legalized the commercialization of CBD-based products as long as they do not contain any more than 0.3% THC...

AMBS : 0.0131 (-0.76%)
CBWTF : 0.5140 (+2.70%)
XLY.VN : 0.680 (+3.03%)
CNAB : 0.1379 (unch)
GBLX : 0.0390 (+0.52%)
ITHUF : 1.4744 (+5.31%)
IAN.CN : 1.960 (+7.69%)
OTC Stock Review Features Four CBD Stocks for 2020

CBD products are becoming extremely popular as consumers discover the benefits of cannabidiol in industries like cosmetics, health products, food and beverage, pet products, skin care, and pharmaceuticals....

CANB : 0.0171 (+1.79%)
GBLX : 0.0390 (+0.52%)
CANN : 0.5913 (-3.07%)
CURLF : 6.6350 (+2.71%)
Consumer Spending on Cannabis Grows as More Dispensaries Open Their Doors

The U.S. cannabis industry has drastically evolved ever since Colorado and Washington decided to legalize recreational cannabis five years ago. The two states were the first in the U.S. to fully legalize...

GOHE : 0.0329 (-0.30%)
ITHUF : 1.4744 (+5.31%)
IAN.CN : 1.960 (+7.69%)
ALEAF : 0.4978 (+4.80%)
ALEF.TO : 0.65 (+1.56%)
CNAB : 0.1379 (unch)
GBLX : 0.0390 (+0.52%)
GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master Research and Development Agreement

The Sale, Which Immediately Eliminates Substantial Cash Obligations and Operating Expenses, Is Collateralized by Wellcana Plus's Interest in GB Sciences Louisiana.

GBLX : 0.0390 (+0.52%)
GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master Research and Development Agreement

The Sale, Which Immediately Eliminates Substantial Cash Obligations and Operating Expenses, Is Collateralized by Wellcana Plus's Interest in GB Sciences Louisiana.

GBLX : 0.0390 (+0.52%)
The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed

GB Sciences, Inc. (OTCQB: GBLX) announces a delay in the sale of GB Sciences Louisiana LLC.

GBLX : 0.0390 (+0.52%)
The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed

GBLX : 0.0390 (+0.52%)
ï"GB Sciences Welcomes Esteemed Patent and Intellectual Property Attorney, Mr. Edmond DeFrank, to Its Board of Directors

GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce that on October 23rd Mr. Edmond DeFrank joined its Board of Directors, filling a vacant seat. Mr. DeFrank is an attorney in the cannabis sector with...

GBLX : 0.0390 (+0.52%)
GB Sciences Welcomes Esteemed Patent and Intellectual Property Attorney, Mr. Edmond DeFrank, to Its Board of Directors

LAS VEGAS , Oct. 31, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce that on October 23 rd Mr. Edmond DeFrank joined its Board of Directors, filling a vacant...

GBLX : 0.0390 (+0.52%)
GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine

In the October 2019 Issue of Marijuana Business Magazine, Dr. Andrea Small-Howard Explains Why GBS is Well Positioned in New Market Segments as the Medical Cannabis Industry Evolves

GBLX : 0.0390 (+0.52%)
GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine

In the October 2019 Issue of Marijuana Business Magazine, Dr. Andrea Small-Howard Explains Why GBS is Well Positioned in New Market Segments as the Medical Cannabis Industry Evolves

GBLX : 0.0390 (+0.52%)
GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine

In the October 2019 Issue of Marijuana Business Magazine, Dr. Andrea Small-Howard Explains Why GBS is Well Positioned in New Market Segments as the Medical Cannabis Industry Evolves

GBLX : 0.0390 (+0.52%)
GB Sciences Sells Its Louisiana Medical Marijuana Business At A $32 Million Total Valuation

LAS VEGAS , Sept. 17, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX), on Friday, September 13, 2019 , filed an 8k announcing the sale of its 50% ownership stake in GB Sciences Louisiana,...

GBLX : 0.0390 (+0.52%)
GB Sciences Sells Its Louisiana Medical Marijuana Business At A $32 Million Total Valuation

GB Sciences, Inc. (OTCQB: GBLX), on Friday, September 13, 2019, filed an 8k announcing the sale of its 50% ownership stake in GB Sciences Louisiana, LLC. The stake will be purchased by Wellcana Plus LLC,...

GBLX : 0.0390 (+0.52%)
U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-Three Applications to Become a DEA-Registered Cannabis Supplier to U.S. Marijuana Researchers

GB Sciences, Inc. (OTCQB: GBLX) today announced that it has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the pending applications, the DEA intends...

GBLX : 0.0390 (+0.52%)
U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-Three Applications to Become a DEA-Registered Cannabis Supplier to U.S. Marijuana Researchers

GB Sciences, Inc. (OTCQB: GBLX) today announced that it has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the pending applications, the DEA intends...

GBLX : 0.0390 (+0.52%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +2.63 , SEDG +7.11 , THC +1.13 , TER +1.66 , LITE +1.85
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar